SynthesisJournal for immunotherapy of cancer2018

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis.

Yixin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.